Sisram Medical Statistics
Total Valuation
Sisram Medical has a market cap or net worth of HKD 1.41 billion. The enterprise value is 1.43 billion.
| Market Cap | 1.41B |
| Enterprise Value | 1.43B |
Important Dates
The last earnings date was Monday, March 23, 2026.
| Earnings Date | Mar 23, 2026 |
| Ex-Dividend Date | Aug 26, 2025 |
Share Statistics
Sisram Medical has 468.34 million shares outstanding.
| Current Share Class | 468.34M |
| Shares Outstanding | 468.34M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.14% |
| Owned by Institutions (%) | 0.47% |
| Float | 133.16M |
Valuation Ratios
The trailing PE ratio is 9.56 and the forward PE ratio is 6.22.
| PE Ratio | 9.56 |
| Forward PE | 6.22 |
| PS Ratio | 0.50 |
| PB Ratio | 0.36 |
| P/TBV Ratio | 0.84 |
| P/FCF Ratio | 26.66 |
| P/OCF Ratio | 19.34 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.13, with an EV/FCF ratio of 27.03.
| EV / Earnings | 9.69 |
| EV / Sales | 0.50 |
| EV / EBITDA | 4.13 |
| EV / EBIT | 6.76 |
| EV / FCF | 27.03 |
Financial Position
The company has a current ratio of 2.60, with a Debt / Equity ratio of 0.10.
| Current Ratio | 2.60 |
| Quick Ratio | 1.62 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | 1.17 |
| Debt / FCF | 7.59 |
| Interest Coverage | 8.33 |
Financial Efficiency
Return on equity (ROE) is 5.06% and return on invested capital (ROIC) is 4.89%.
| Return on Equity (ROE) | 5.06% |
| Return on Assets (ROA) | 2.63% |
| Return on Invested Capital (ROIC) | 4.89% |
| Return on Capital Employed (ROCE) | 4.91% |
| Weighted Average Cost of Capital (WACC) | 9.56% |
| Revenue Per Employee | 2.73M |
| Profits Per Employee | 142,317 |
| Employee Count | 1,047 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 1.72 |
Taxes
In the past 12 months, Sisram Medical has paid 27.59 million in taxes.
| Income Tax | 27.59M |
| Effective Tax Rate | 12.42% |
Stock Price Statistics
The stock price has decreased by -30.39% in the last 52 weeks. The beta is 1.18, so Sisram Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.18 |
| 52-Week Price Change | -30.39% |
| 50-Day Moving Average | 3.53 |
| 200-Day Moving Average | 4.61 |
| Relative Strength Index (RSI) | 35.55 |
| Average Volume (20 Days) | 519,675 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sisram Medical had revenue of HKD 2.84 billion and earned 148.01 million in profits. Earnings per share was 0.32.
| Revenue | 2.84B |
| Gross Profit | 1.67B |
| Operating Income | 210.38M |
| Pretax Income | 222.22M |
| Net Income | 148.01M |
| EBITDA | 297.50M |
| EBIT | 210.38M |
| Earnings Per Share (EPS) | 0.32 |
Balance Sheet
The company has 568.49 million in cash and 402.82 million in debt, giving a net cash position of 165.68 million or 0.35 per share.
| Cash & Cash Equivalents | 568.49M |
| Total Debt | 402.82M |
| Net Cash | 165.68M |
| Net Cash Per Share | 0.35 |
| Equity (Book Value) | 3.92B |
| Book Value Per Share | 7.97 |
| Working Capital | 1.32B |
Cash Flow
In the last 12 months, operating cash flow was 73.15 million and capital expenditures -20.10 million, giving a free cash flow of 53.05 million.
| Operating Cash Flow | 73.15M |
| Capital Expenditures | -20.10M |
| Depreciation & Amortization | 87.70M |
| Net Borrowing | -19.59M |
| Free Cash Flow | 53.05M |
| FCF Per Share | 0.11 |
Margins
Gross margin is 58.89%, with operating and profit margins of 7.40% and 5.20%.
| Gross Margin | 58.89% |
| Operating Margin | 7.40% |
| Pretax Margin | 7.81% |
| Profit Margin | 5.20% |
| EBITDA Margin | 10.46% |
| EBIT Margin | 7.40% |
| FCF Margin | 1.87% |
Dividends & Yields
This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 3.15%.
| Dividend Per Share | 0.10 |
| Dividend Yield | 3.15% |
| Dividend Growth (YoY) | -20.25% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 39.64% |
| Buyback Yield | n/a |
| Shareholder Yield | 3.04% |
| Earnings Yield | 10.46% |
| FCF Yield | 3.75% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Sisram Medical has an Altman Z-Score of 2.48 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.48 |
| Piotroski F-Score | 4 |